SAN FRANCISCO–(BUSINESS WIRE)–VeriSIM Life today announced that it has entered into an agreement with the Department of War to advance computational New Approach Methodologies (NAMs) for medical countermeasure development and safety assessment. Under the agreement, VeriSIM Life will use its BIOiSIM® platform to develop and evaluate computational models that integrate biological, experimental, and drug-specific data to better understand how findings from preclinical systems translate to humans